Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United States

Among US women who are ≥30 years old, HPV DNA and Papanicolaou testing is a reasonable cervical cancer screening strategy.